Feedback / Questions
ALRN-6924 - Aileron
https://www.prnewswire.com/news-releases/aileron-therapeutics-and-advancium-health-network-announce-an-exclusive-option-agreement-for-the-acquisition-of-alrn-6924-for-retinoblastoma-302292196.html
Oct 31, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next